Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Baffi currently holds 12,050 shares of Neurogene Inc. (NGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Baffi has been a net seller of NGNE stock. They have purchased $67.2K and sold $41.3M worth of shares.
Robert Baffi's most recent insider trade was on Feb 20, 2026, when they sold 12,050 shares at $0.00 per share.
Robert Baffi serves as Executive at Neurogene Inc. (NGNE). They have executed 626 insider transactions totaling $41.3M over their tenure at the company.
Robert Baffi holds the position of Executive at Neurogene Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Robert Baffi has shown a selling trading pattern, with $67.2K in total purchases and $41.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Baffi was on Feb 29, 2016, when they sold $3.9M worth of BMRN shares. This transaction involved 47,273 shares at $81.87 per share.
Robert Baffi currently owns 12,050 shares of Neurogene Inc. (NGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Baffi's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Baffi has 626 Form 4 filings on record as an insider at Neurogene Inc..
Set alerts for Robert Baffi and 40,000+ other insiders.